Skip to main content
Journal ArticleOPEN ACCESS

Ganciclovir and Valganciclovir Use Among Infants With Congenital Cytomegalovirus: Data From a Multicenter Electronic Health Record Dataset in the United States

Journal of the Pediatric Infectious Diseases Society (2022) 11(8) 379-382
DOI: 10.1093/jpids/piac034
11Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Among 342 US infants with congenital cytomegalovirus treated with antivirals, 114 (33%) received ganciclovir (with or without valganciclovir) and 228 (67%) received valganciclovir only, for a median of 8 and 171 days, starting at a median of 15 and 45 days of life, respectively, with neutropenia diagnosed in 25% and 17%.

Author supplied keywords

Cite

CITATION STYLE

APA

Leung, J., Grosse, S. D., Yockey, B., & Lanzieri, T. M. (2022). Ganciclovir and Valganciclovir Use Among Infants With Congenital Cytomegalovirus: Data From a Multicenter Electronic Health Record Dataset in the United States. Journal of the Pediatric Infectious Diseases Society, 11(8), 379–382. https://doi.org/10.1093/jpids/piac034

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free